CD36 is a broadly expressed transmembrane protein that engages multiple ligands, including polar lipids. This protein is thought to even contribute to the chemosensory detection of long-chain fatty acids in the oral cavity of rodents. In this study, we assessed whether animals consciously perceive a ligand of CD36, 1-(palmitoyl)-2-(5-keto-6-octanedioyl)phosphatidylcholine (KOdiA-PC), and if so, whether CD36 is involved in sensing the oxidised phospholipid species. We found that mice avoided or hesitated to ingest fluids containing KOdiA-PC, suggesting a conscious perception of the lipid in the animals. We assessed the involvement and role of CD36 in the KOdiA-PC perception by comparing the behavioural responses of wild-type and CD36-deficient mice to the test fluids, and provided evidence that the protein could play a role in sensing a lower level of the lipid. We also found that transection of the olfactory nerve of wild-type mice resulted in an inability to perceive KOdiA-PC, suggesting the significance of olfactory system in the lipid sensing. Our findings, coupled with the recent finding of CD36 expression in the mouse olfactory epithelium, led us to predict that the site of CD36 action in the KOdiA-PC sensing plausibly lies within the nasal cavity of the animal.
Animals have highly developed chemosensory systems that enable efficient detection of diverse soluble or volatile molecules. Detection of exogenous molecules by taste bud cells and/or olfactory receptor cells transmits signals to the brain and consequently induces various behavioural responses (e.g., appetitive or aversive response to foods) (21, 25) . To better understand the mechanisms underlying chemosensory perception, much effort has gone into identifying sensory proteins in the oral and nasal cavities (4, 5) . CD36 is a broadly expressed transmembrane protein associated with the recognition of multiple molecules (e.g., amphipathic lipids) (15, 19) . For instance, in macrophages, CD36 contributes to the clearance of oxidised forms of low-density lipoprotein from the blood by recognising distinct phospholipid species on the surface of the particles (6, 20) . Furthermore, CD36 expressed by enterocytes is believed to participate in not only recognition and absorption of long-chain fatty acids but also in formation of chylomicrons (18) . In addition to its well-characterized functions, CD36 has been postulated to play an important role in the chemosensory detection of longchain fatty acids in the oral cavity, leading to an appetitive response to the lipid species in rodents. Several lines of evidence support this finding: CD36 is localised to the apical surface of taste bud cells in viously (17) . Briefly, mice were anesthetized with 1% sodium pentobarbital (10 μL/g body weight) and placed in a stereotaxic instrument using ear bars and an incisor holder to immobilize the head. The right and left olfactory bulbs were exposed, a 0.2-mm thick Teflon blade was inserted between the olfactory bulbs and cribriform plate, and then a bilateral transection of olfactory nerve fibres was performed. The skin incision was closed with a nylon suture. The surgical-control (sham) mice underwent the same surgical procedure without transection of olfactory nerve fibres. The reduction or loss of olfaction by the nerve transection was confirmed as previously described (17) .
Preparation of test fluids. KOdiA-PC was obtained from Cayman Chemical (Ann Arbor, MI, USA). The original container contained 5 mg KOdiA-PC in 1 mL ethanol. Another phospholipid species, 1-(palmitoyl)-2-(arachidonyl)-sn-phosphatidylcholine (PAPC), was obtained from Hycult Biotech Inc. (Plymouth Meeting, PA, USA). The original container includes 5 mg of dried synthetic PAPC. PAPC was dissolved in 1 mL of ethanol (≥99.5%; Nacalai Tesque, Kyoto, Japan). KOdiA-PC and PAPC in ethanol were stored at −70°C until use. Immediately prior to the experiment, both the test fluids and vehicle control were prepared by adding of phospholipid species in ethanol and ethanol alone to 0.15 M sucrose (Nacalai Tesque) solution, respectively.
Two-bottle choice test.
Prior to the experiments, each mouse was first given a 0.3 M sucrose solution and distilled water for 10 min. This was repeated for 3 days. The mice were then given ad libitum access to a 0.15 M sucrose solution and distilled water for 10 min. After mice learned to select the 0.15 M sucrose solution for 2 consecutive days, they were tested. Mice were deprived of water and food 1 h prior to the test, during which test fluids were presented to the mice for 10 min. The fluid consumption in each cage was measured as a weight and was expressed as grams consumed per cage. In tests using a fluid containing the lower concentration of KOdiA-PC, they were repeated for 3 days. To avoid developing a preference for a particular side (left or right), the positions of fluids were randomly altered every day throughout all training and test periods.
Licking test. The principle and apparatus involved with the licking test were previously described (29) . Briefly, prior to the experiments, mice were trained to ingest sufficient amounts of a sucrose solution the circumvallate papillae of rats (9) , long-chain fatty acids increase the concentration of intracellular free calcium in taste bud cells where CD36 is likely to be expressed (1) , and mice with CD36 gene disruption exhibit a reduced preference to long-chain fatty acids such as linoleate (12) . A species of oxidised phospholipid, 1-(palmitoyl)-2-(5-keto-6-octene-dioyl)phosphatidylcholine (KOdiA-PC), is one of the most potent CD36 ligands (20) . Oxidised forms of phospholipids, including KOdiA-PC, are believed to occur on the surface of low-density lipoproteins circulating in the blood during periods of oxidative stress and on the surface of cells undergoing apoptosis (10, 20) . Animals, including humans, might occasionally encounter or even ingest such phospholipid species in the environment. It is, however, unknown whether animals consciously perceive these phospholipid species occurring outside the body and, if so, whether CD36 is involved in the process of perception. In the present study, we provided evidence (i) that mice could perceive KOdiA-PC and (ii) CD36 could contribute to the sensing of a lower level of the oxidised phospholipid species in the animal. We also demonstrate that the perception of KOdiA-PC relies considerably on the olfactory system in the animal.
MATERIALS AND METHODS
Animals. CD36-knockout mice (C57BL6/J background) (16) were provided as previously described (8) . Wild-type and CD36-knockout littermates were obtained from the same breeding pair and thus have a genetically identical background. To genotype the mice lines, we used the primer set described in a previous study (16) . Mice were bred under a constant temperature (22°C) and a 12 : 12 h light-dark cycle (dark phase of 18 : 00-6 : 00). One week prior to experiments, each mouse was individually housed with ad libitum access to water and standard mouse chow (MF; Oriental Yeast, Japan). All mice used in this study were between 8 and 12 weeks of age. All the tests including the training sessions were performed at 18 : 00 under food and water deprivation that began 1 h prior to the tests. This study was performed in accordance with the ethics guidelines of the Kyoto University Animal Experimentation Committee and was in complete compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Olfactory nerve transection (ONX).
The transection of olfactory nerves was performed as described pre-KOdiA-PC was significantly less than that of the solution alone (Fig. 1B, left panel) . Based on this data, we suggest that the mice could perceive KOdiA-PC and thus avoided or hesitated to ingest the fluid containing the lipid. It is important to assess the involvement and role of CD36 in the perception of KOdiA-PC in the mice. For this, we investigated the choice of the two fluids in C57BL6/J mice with CD36 gene disruption (CD36-knockout mice). If the mice ingested the fluids in a comparable fashion, CD36 involvement in the perception of KOdiA-PC in the wild-type mice would be indicated. Note that the intake pattern for distilled water and 0.15 M sucrose in the CD36-knockout mice was similar to that of the wild-type mice (Fig. 1A , right panel), indicating that CD36 does not affect the perception of sucrose. Like in the wild-type mice, the intake of the sucrose solution with KOdiA-PC was significantly less than the intake of the solution alone in CD36-knockout mice (Fig. 1B , right panel). Two-way repeated measures ANOVA gave a P-value of more than 0.5 for the KOdiA-PC × CD36 gene disruption interaction. These results suggest that the wild-type mice do not require CD36 for perceiving KOdiA-PC under this experimental condition.
Perception of a lower level of KOdiA-PC and the involvement of CD36 in mice
We next assessed if mice could perceive a lower level of KOdiA-PC using the two-bottle choice test: with and without KOdiA-PC (7.5 μM). The phospholipid at concentrations of less than 50 μM has been shown to exhibit little inhibition in the binding of oxidised low-density lipoproteins to the model CD36 in physiological buffered saline (23) . For an accurate assessment, we used 0.15 M sucrose solution as control vehicle. On the first trial, the wild-type mice ingested both fluids in a similar manner ( Fig. 2A, left panel) . We repeated the test for an additional 2 days. On the second and third trials of test, the intake of the sucrose solution containing KOdiA-PC was less than that of the solution alone ( Fig. 2A, left panel) . In addition, the intake volume of the sucrose solution increased as the days went on (P = 0.024, one-way repeated measures ANOVA), whereas that of the solution with KOdiA-PC did not (P = 0.54, one-way repeated measures ANOVA). These results led us to suggest that the mice could perceive KOdiA-PC in the fluid and hesitated to ingest it. KOdiA-PC is believed to be an oxide of PAPC (a typical of phospholipid) that is incapable of binding to CD36 (20, within 10 min. Mice were deprived of water and food for 1 h, and then the sucrose solutions were presented to the animals in home cages for 10 min. This training was repeated for 5 days. After training, mice were placed in the licking test chamber for 1 h without any fluids present for habituation to the test environment. The following day, mice were placed without food and water for 1 h in the test chamber, during which time 0.15 M sucrose solution was presented to the mice for 10 min. During the presentation, the number of licks was recorded. This was repeated for 5 consecutive days. After this 5-day period, mice were subjected to a licking test using a 0.15 M sucrose solution containing KOdiA-PC. This procedure was repeated for 3 days. The initial licking rate was calculated by counting the number of licks for 1 min following after the first lick.
Statistical analysis. Repeated measures analysis of variance (ANOVA) and Bonferroni post hoc test were used for statistical analyses by means of the aid of Prism 5 software package (GraphPad, San Diego, CA, USA). A P-value of less than 0.05 was considered to be statistically significant.
RESULTS

Assessment of the perception of KOdiA-PC in mice
In the present study, we first assessed whether animals could consciously perceive KOdiA-PC. For this, we conducted a test where animals were offered the choice of a pair of fluids (two-bottle choice test). The conscious perception of a substance of interest could be measured by comparing the intake of fluids with or without it. We initially performed a test in which C57BL6/J mice were given the choice of distilled water with and without KOdiA-PC. We previously determined the concentration of KOdiA-PC necessary to achieve half-maximal inhibition of oxidised LDL binding to a model CD36 peptide (0.075 to 0.1 mM) (23) . We therefore, set the concentration of KOdiA-PC at 0.15 mM, expecting the animals to perceive it. However, we could not evaluate the perception of KOdiA-PC in the animals, because the intake of distilled water was low (data not shown). By referring to studies on the evaluation of accessibility of bitter compounds in animals (14, 28), we then performed another two-bottle choice test using a sucrose solution as vehicle control. We set the concentration of sucrose at 0.15 M, because the intake of the solution was significantly higher than that of distilled water (Fig. 1A, left panel) . The intake of the sucrose solution with 0.15 mM CD36 may play a role in the perception of a lower level of KOdiA-PC in mice. Like the wild-type mice, the CD36-knockout mice consumed 0.15 M sucrose solution with and without PAPC (6.4 μM) in a comparable manner (Fig. 2B, right panel) , suggesting that CD36 deletion does not affect the behavioural responses to PAPC.
Further assessment of CD36 involvement in the perception of a lower level of KOdiA-PC by a licking test
To further support CD36 involvement in the perception of a lower level of KOdiA-PC, we performed a brief-access licking test where the acceptability of test fluids could be measured without considering post-ingestive influences. The wild-type and CD36-knockout mice were given a 0.15 M sucrose solution on the first five trials. During these trials, the initial licking rates were similar between the mouse lines (Fig. 3, Day 1 to 5) . From the day 6 to 8, both lines of mice were exposed to 0.15 M sucrose solution containing 7.5 μM KOdiA-PC. The initial licking rate in the wild-type mice decreased as the days went on, while that of the CD36-knockout mice remained unchanged (Fig. 3, Day 6 to 8) . On the final trial, the initial liking rate was significantly lower in 23, 26) . We found that the wild-type mice ingested 0.15 M sucrose solution with and without PAPC (6.4 μM) in a comparable manner (Fig. 2B left panel) . Therefore, we believe that the ingestive behaviour of mice in the two-bottle choice test using 7.5 μM of KOdiA-PC is not an artifact. The wild-type mice did not appear to perceive KOdiA-PC at a concentration of 0.75 μM in sucrose solutions (data not shown). The CD36-knockout mice were also subjected to the two-bottle choice test using 0.15 M sucrose solution with and without KOdiA-PC (7.5 μM). The mice ingested the two fluids in a comparable manner during at each trial ( Fig. 2A, right panel) . We conducted two-way repeated measures ANOVA per trial to assess the effects of CD36 gene disruption on the choice of the two fluids. The P-value obtained in the context of the first, second and third trials were 0.52, 0.18 and 0.011 for the effect of KOdiA-PC, 0.49, 0.53 and 0.70 for the effect of CD36 gene disruption and 0.62, 0.30 and 0.14 for the KOdiA-PC × CD36 gene disruption interaction, respectively. Bonferroni post hoc test detected a statistically significant difference between the intake volumes of the two fluids in the wild-type mice on the third trial ( Fig. 2A) . Collectively, we suggest that the wild-type mice (100 ± 9/min) than in the CD36-knockout mice (177 ± 21/min). These results support the importance of CD36 in the perception of a low level of KOdiA-PC.
The effect of ONX on KOdiA-PC perception in mice
The findings that the wild-type mice still noticed the lower level of KOdiA-PC led us to postulate that the olfactory system, responsible for highly sensitive detection of odorants (4, 24, 25) , is critical for perception of the phospholipid. To test our hypothesis, we examined the effects of ONX on the ingestion of fluid with KOdiA-PC. The wild-type mice with sham surgery and those with ONX were offered the choice of 0.15 M sucrose solution with and without KOdiA-PC (7.5 μM). Note that our surgical operation did not seriously affect the choice of distilled water and 0.15 M sucrose solution in the mice (Fig. 4A) .
On the first trial, the mice with sham surgery ingested the two fluids equally (Fig. 4B, left panel) . On the second and third trials, the intake of the solution with KOdiA-PC was less than that of the solution alone (Fig. 4B, left panel) . Note that unlike in no-surgery mice (refer to Fig. 2A, left panel) , the intake volume of 0.15 M sucrose solution in the shamoperated mice did not increase during these trials (P = 0.12, one-way repeated measures ANOVA), indicating that the sham surgery resulted in a decline in the appetite for the solution. Nonetheless, the mean values for intake of fluid containing KOdiA-PC at levels lower than those of the control vehicle on the second and third trials led us to suggest that the sham-operated mice were still capable of perceiving the lipid. In the mice with ONX, the intake volumes of the two fluids were comparable for each trial (Fig. 4B,   Fig. 2 Assessment of the perception of KOdiA-PC (7.5 μM) and CD36 involvement in mice. Wild-type and CD36-knockout mice were given 0.15 M sucrose solution with and without KOdiA-PC (A) or that with and without PAPC (6.4 M) (B) at the same time for 10 min. The test was repeated for 3 days. Each column and bar represents the intake ± S.E. of at least 8 cages. In (A) and (B), the effects of CD36 gene disruption were analysed per day by using two-way repeated measures ANOVA and Bonferroni post hoc test. In (A), the P-values obtained for the KOdiA-PC effect, the CD36 gene disruption effect and the KOdiA-PC × CD36 gene disruption interaction were described in the RESULTS section. *P < 0.05 versus the intake of sucrose solution alone. In (B), the P-value obtained in the context of the first, second and third trials were 0.20, 0.99 and 0.089 for the effect of PAPC, 0.20, 0.29 and 0.42 for the effect of CD36 gene disruption and 0.72, 0.50 and 0.40 for the PAPC × CD36 gene disruption interaction, respectively. Bonferroni post hoc test did not detect statistically significant differences between the intake volumes of the two fluids with or without PAPC on each trial in either wild-type or CD36-knockout mice.
CD36 could contribute to the perception of KOdiA-PC in mice. However, the protein appeared to be required only for an efficient recognition of the lipid by the animals. Indeed, the effects of CD36 deletion on the ingestive response to the KOdiA-PC-containing fluid became detectable only when the lipid was applied at a lower level (Figs. 1 to 3 ). There is a family of membrane proteins in insects called sensory neuron membrane proteins (SNMPs) that have similar structural features to CD36 (3, 11) . Of these, SNMP-1 is believed to facilitate the detection of pheromones via a G-protein coupled receptor expressed by the sensory neurons (7) . By analogy, we suggest that CD36 may play a supportive role in the detection of KOdiA-PC by an unknown signal transduction receptor(s). Indeed, CD36 is a cofactor of the toll-like receptor 2 and enhances recognition of lipoteichoic acid by this receptor (2) . It should be noted that mice did not hesitate to ingest the fluid containing 7.5 μM KOdiA-PC at the first trial but did hesitate at the second and third trials ( Fig. 2A) . These results suggest that the mice did not perceive the KOdiA-PC in the fluid as unpleasant at the initial trial and that it is not until the animals perceives some discomfort after ingestion of the fluid that they considered it hazardous during the following trials. In other words, an aversive feedback mechanism is required to elicit a behavright panel). We analysed the effect of ONX on the choice of the two fluids by performing two-way repeated measures ANOVA per trial. The P-value obtained in the context of the first, second and third trials were 0.12, 0.018 and 0.94 for the effect of KOdiA-PC, 0.58, 0.88 and 0.83 for the effect of ONX and 0.53, 0.090 and 0.10 for the KOdiA-PC × ONX interaction, respectively. Bonferroni post hoc test detected a statistically significant difference between the intake volumes of the two fluids on the second trial in mice with sham surgery but not in those with ONX (Fig. 4B, left panel) . Collectively, we suggest the importance of an intact olfactory system for perceiving a low level of KOdiA-PC. We have shown the perception of KOdiA-PC in mice by a two-bottle choice test using fluids with or without the lipid at a concentration more than an order of magnitude larger than 7.5 μM (0.15 mM) (Fig. 1B) . In the present study, we also sought to evaluate the involvement of olfactory system in the perception of the level of KOdiA-PC. For this, we conducted an experiment in which the wild-type mice with sham surgery and ONX were given the choice of 0.15 M sucrose solution with and without KOdiA-PC (0.15 mM). The intake of the sucrose solution with KOdiA-PC was less than that of the solution alone in the mice receiving the sham operation (Fig. 4C, left panel) . Note that the intake of sucrose solution alone was lower in the sham-operated mice (0.43 ± 0.027 g) than in the no-surgery mice (0.65 ± 0.013 g, refer to Fig. 1B, left panel) , reinforcing the idea that our sham surgery affects the intake of the solution. Nonetheless, the apparent difference between the intake volumes of the sucrose solutions with or without KOdiA-PC conveys the perception of KOdiA-PC in the sham-operated mice. The ONX mice ingested the two fluids in a comparable manner (Fig. 4C, right panel) . Two-way repeated measures ANOVA gave a P-value of less than 0.01 for the KOdiA-PC × ONX interaction. These results suggest that the perception of higher levels of KOdiA-PC also relies considerably on olfactory system in mice.
DISCUSSION
In the present study, we found that mice avoided or hesitated to ingest fluids containing KOdiA-PC. The findings provide strong evidence for conscious perception of the oxidised phospholipid species in the animal. Considering the radical nature of products of lipid oxidation, we infer that KOdiA-PC may produce an irritant and/or unpleasant sensation in the animal. Furthermore, we provided evidence that Fig. 3 Assessment of CD36 involvement in the perception of KOdiA-PC using a licking test. In this test, 8 and 9 of wild-type and CD36-knockout mice, respectively, were given 0.15 M sucrose solution for 5 days and the solution containing 7.5 μM KOdiA-PC for 3 days. The initial licking rates were calculated as described in Materials and methods. Data are expressed as mean ± SE. Statistical analysis was performed using two-way repeated measures ANOVA and Bonferroni post hoc test. The P-values obtained were 0.25 for the effect of CD36 gene disruption, less than 0.0001 for the effect of day and 0.070 for the CD36 gene disruption × day interaction. *, P < 0.05 versus the initial licking rate in CD36-knockout mice at day 8.
saccharin solution even when conditioned with intragastric KOdiA-PC in a conditioned taste aversion test (our unpublished observation). Rather, our present data support the significance of chemosensory inputs through the oral and/or nasal cavity to assess ioural response. However, direct addition of KOdiA-PC to the gastrointestinal tracts or inside the body did not appear to modulate the aversive feedback. This idea is supported by the observation that the mice demonstrated little or no latency to ingest a . Each column and bar represents the intake ± SE of at least 8 cages. Statistical analysis was performed using two-way repeated measures ANOVA and Bonferroni post hoc test. In (A), the P-values obtained were less than 0.0001 for the effect of sucrose, 0.22 for the effect of ONX and 0.13 for the sucrose × ONX interaction. ***P < 0.001, **P < 0.01 versus the intake of distilled water. In (B), the effects of ONX were assessed per trial. The P-values obtained for the KOdiA-PC effect, the ONX effect and the KOdiA-PC × ONX interaction were described in the RESULTS section. *P < 0.05 versus the intake of sucrose solution alone. In (C), the P-values obtained were 0.0019 for the effect of KOdiA-PC, 0.049 for the effect of ONX and 0.0095 for the KOdiA-PC × ONX interaction. **P < 0.01 versus the intake of sucrose solution alone.
are responsible for KOdiA-PC recognition. The putative unknown receptor(s) may not necessarily require the assistance of CD36 for the detection of high levels of KOdiA-PC. Further studies are required to clarify the role(s) of CD36 in the perception of KOdiA-PC, including that in the olfactory system, in animals.
